Capital Flow Monitor · Sponsors · CIK 2157427
Xact Bio, Inc.
501 BOYLSTON STREET, 9TH FLOOR, BOSTON, MA, 02116 · 000-000-0000
Biotechnology · Corporation· inc. DELAWARE true 2024
Fit score
—
Offering
$18.0M
Sold
$10.0M
% sold
55.6%
Investors
3
Min investment
$0
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2026-09-28 | D ·current | 506(b) | $18.0M | $10.0M | 55.6% | 3 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.
-
Eric Green — Executive Officer / Director, Boston, MA
2 other raises
- Dignify Therapeutics, LLC $800K of $3.0M · 26.7%
- Hines Rialto Credit Partners, LP $1.08B of —
-
Uciane Scarlett — Executive Officer / Director, Boston, MA
1 other raise
- Alaris Ventures Fund I, L.P. $0 of —
- Chengjung Lai — Director, Boston, MA
- Jian Shao — Director, Boston, MA
Placement agents
- No sales compensation reported — direct raise.
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.